Production (Stage)
Ligand Pharmaceuticals Incorporated
LGND
$105.99
$1.811.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -32.74% | 50.41% | 15.30% | 3.60% | 9.88% |
| Total Receivables | 70.55% | 7.98% | 35.35% | 38.18% | 6.33% |
| Inventory | -31.51% | -41.12% | -34.07% | -30.60% | 52.29% |
| Prepaid Expenses | -- | 63.62% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 597.73% | 535.94% | 1,057.56% | 840.90% | 102.10% |
| Total Current Assets | -16.15% | 39.65% | 21.81% | 12.85% | 12.41% |
|
|
|||||
| Total Current Assets | -16.15% | 39.65% | 21.81% | 12.85% | 12.41% |
| Net Property, Plant & Equipment | -56.97% | -1.02% | -3.03% | -4.06% | -10.86% |
| Long-term Investments | -3.52% | 1.82% | 1.43% | -0.40% | -0.40% |
| Goodwill | -3.52% | 1.82% | 1.43% | -0.40% | -0.40% |
| Total Other Intangibles | -11.33% | -11.00% | -14.48% | -15.77% | -15.37% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 179.18% | 179.73% | 1,238.64% | 875.80% | 1,296.53% |
| Total Assets | -0.92% | 19.63% | 24.13% | 14.29% | 12.67% |
|
|
|||||
| Total Accounts Payable | 183.47% | 115.62% | 89.66% | -81.29% | -69.14% |
| Total Accrued Expenses | 166.67% | 153.01% | 64.30% | 99.31% | -47.02% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -11.96% | 214.63% | 119.32% | 71.76% | -98.71% |
| Total Finance Division Other Current Liabilities | 347.60% | 31.26% | 22.48% | -59.12% | 2,056.48% |
| Total Other Current Liabilities | 347.60% | 31.26% | 22.48% | -59.12% | 2,056.48% |
| Total Current Liabilities | 229.35% | 121.14% | 57.51% | -36.83% | -81.99% |
|
|
|||||
| Total Current Liabilities | 229.35% | 121.14% | 57.51% | -36.83% | -81.99% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -31.76% | 1.56% | 7.46% | -41.63% | -53.29% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -43.48% | 7.23% | 3.61% | 25.35% | 54.27% |
| Total Liabilities | 2.38% | 29.00% | 12.20% | -2.15% | -34.85% |
|
|
|||||
| Common Stock & APIC | 56.02% | 69.79% | 68.12% | 39.90% | 41.33% |
| Retained Earnings | -22.51% | -0.80% | 9.33% | 8.51% | 19.55% |
| Treasury Stock & Other | -71.76% | -627.29% | 284.96% | 3.31% | 2.67% |
| Total Common Equity | -1.36% | 18.48% | 25.94% | 16.59% | 24.79% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.36% | 18.48% | 25.94% | 16.59% | 24.79% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.36% | 18.48% | 25.94% | 16.59% | 24.79% |
|
|
|||||